Literature DB >> 32463432

Reproductive system infections in women: lower genital tract syndromes.

Robert C Brunham1, Jorma Paavonen2.   

Abstract

Gynecological and obstetrical infectious diseases are an important component of women's health. A system approach to gynecological and obstetrical infection helps unify and classify microbial etiology and pathogenesis within a clinical anatomical framework of lower and upper genital tract syndromes. The reproductive system of women includes the vulva, vagina, cervix, uterus, fallopian tubes and ovaries. During pregnancy, additional tissues include the chorioamnion and placenta together with the fetus and amniotic fluid. We review in two parts reproductive system infection syndromes in women using selected research results to illustrate the clinical utility of the system approach in terms of diagnosis, treatment and prevention. We conclude that a reproductive system perspective will lead to improvements in understanding, management and prevention of these diseases. © FEMS 2020.

Entities:  

Keywords:  zzm321990 Chlamydia trachomatiszzm321990 ; neonatal and infant health; reproductive system infections; sexually transmitted diseases; women's health

Mesh:

Year:  2020        PMID: 32463432     DOI: 10.1093/femspd/ftaa022

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  2 in total

1.  Induction of Protection in Mice against a Chlamydia muridarum Respiratory Challenge by a Vaccine Formulated with the Major Outer Membrane Protein in Nanolipoprotein Particles.

Authors:  Delia F Tifrea; Wei He; Sukumar Pal; Angela C Evans; Sean F Gilmore; Nicholas O Fischer; Amy Rasley; Matthew A Coleman; Luis M de la Maza
Journal:  Vaccines (Basel)       Date:  2021-07-07

2.  Reduced Uterine Tissue Damage during Chlamydia muridarum Infection in TREM-1,3-Deficient Mice.

Authors:  Bryan E McQueen; Avinash Kollipara; Clare E Gyorke; Charles W Andrews; Ashley Ezzell; Toni Darville; Uma M Nagarajan
Journal:  Infect Immun       Date:  2021-06-14       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.